US Stock MarketDetailed Quotes

Arcturus Therapeutics (ARCT)

Watchlist
  • 7.470
  • -0.360-4.60%
Close May 15 16:00 ET
  • 7.440
  • -0.030-0.40%
Pre 07:14 ET
212.32MMarket Cap-2.64P/E (TTM)

Arcturus Therapeutics (ARCT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
44.67%-19.44M
-24.31%-74.27M
-5,613.73%-16.23M
27.83%-17.15M
80.91%-5.76M
-532.32%-35.14M
-230.11%-59.75M
54.85%-284K
26.67%-23.76M
-159.33%-30.14M
Net income from continuing operations
-91.56%-26.96M
18.73%-65.78M
3.09%-29.08M
-94.81%-13.45M
46.68%-9.18M
47.51%-14.08M
-172.30%-80.94M
-156.30%-30.01M
57.45%-6.9M
67.24%-17.22M
Operating gains losses
-257.14%-33K
-18.90%382K
136.63%63K
-15.84%170K
-67.01%128K
-60.38%21K
101.39%471K
---172K
388.57%202K
--388K
Depreciation and amortization
-17.85%658K
-14.64%3.03M
-16.73%682K
-16.34%763K
-14.30%779K
-11.39%801K
19.85%3.54M
0.49%819K
10.28%912K
23.34%909K
Change In working capital
109.01%2.57M
-88.38%-39.2M
-83.11%3.39M
62.27%-10.37M
84.43%-3.68M
-379.45%-28.55M
-381.93%-20.81M
1,287.50%20.09M
-4.80%-27.47M
-125.09%-23.65M
-Change in receivables
139.83%4.22M
-105.66%-1.59M
-90.90%2.39M
251.34%9.25M
-188.56%-2.63M
-311.66%-10.6M
195.87%28.09M
326.01%26.23M
82.74%-6.11M
-96.69%2.97M
-Change in prepaid assets
-32.75%809K
303.75%5M
159.75%916K
93.29%-57K
230.23%2.94M
-44.97%1.2M
-310.82%-2.46M
-351.72%-1.53M
79.55%-850K
-1,485.89%-2.26M
-Change in payables and accrued expense
85.15%-1.38M
-332.24%-18.22M
-14.09%3.11M
-48.82%-10.46M
-131.94%-1.61M
-249.23%-9.26M
377.67%7.85M
136.62%3.62M
-257.98%-7.03M
149.71%5.05M
-Change in other current assets
-29.63%658K
-18.98%3.7M
-6.82%861K
2.14%955K
7.39%945K
-48.71%935K
12.78%4.56M
-10.64%924K
-8.24%935K
-12.35%880K
-Change in other current liabilities
-9.20%-1.1M
-15.61%-4.21M
-9.30%-1.08M
-9.31%-1.07M
-53.20%-1.05M
-2.02%-1.01M
15.41%-3.65M
10.98%-989K
10.61%-977K
36.06%-688K
-Change in other working capital
93.52%-636K
56.76%-23.87M
65.67%-2.8M
33.10%-8.99M
92.34%-2.27M
-144.57%-9.82M
-243.00%-55.21M
-275.55%-8.16M
-249.39%-13.43M
-302.41%-29.61M
Cash from discontinued investing activities
Operating cash flow
44.67%-19.44M
-24.31%-74.27M
-5,613.73%-16.23M
27.83%-17.15M
80.91%-5.76M
-532.32%-35.14M
-230.11%-59.75M
54.85%-284K
26.67%-23.76M
-159.33%-30.14M
Investing cash flow
Cash flow from continuing investing activities
124.82%34K
64.51%-230K
88K
-126.25%-181K
0
42.92%-137K
77.66%-648K
0
91.85%-80K
7.34%-328K
Net PPE purchase and sale
124.82%34K
64.51%-230K
--88K
-126.25%-181K
--0
42.92%-137K
77.66%-648K
--0
91.85%-80K
7.34%-328K
Cash from discontinued investing activities
Investing cash flow
124.82%34K
64.51%-230K
--88K
-126.25%-181K
--0
42.92%-137K
77.66%-648K
--0
91.85%-80K
7.34%-328K
Financing cash flow
Cash flow from continuing financing activities
-99.89%16K
146.99%13.38M
8,622.39%11.69M
76.77%1.23M
-712.82%-14.73M
594.47%15.2M
122.49%5.42M
100.72%134K
-96.83%693K
2,456.38%2.4M
Net issuance payments of debt
--0
--0
--0
--0
---15M
--15M
--0
--0
--0
--0
Net common stock issuance
----
1,699.56%12.27M
--11.69M
----
----
----
11.99%682K
--0
----
----
Proceeds from stock option exercised by employees
-91.79%16K
-76.58%1.11M
--0
5,718.18%640K
-88.60%274K
-91.09%195K
77.51%4.74M
-90.02%134K
-99.11%11K
2,456.38%2.4M
Cash from discontinued financing activities
Financing cash flow
-99.89%16K
146.99%13.38M
8,622.39%11.69M
76.77%1.23M
-712.82%-14.73M
594.47%15.2M
122.49%5.42M
100.72%134K
-96.83%693K
2,456.38%2.4M
Net cash flow
Beginning cash position
-20.79%232.79M
-15.76%293.91M
-19.32%237.25M
-20.13%253.35M
-20.69%273.83M
-15.76%293.91M
-11.44%348.89M
-20.32%294.06M
-16.65%317.21M
4.61%345.28M
Current changes in cash
3.43%-19.39M
-11.17%-61.12M
-2,867.33%-4.45M
30.43%-16.11M
27.03%-20.48M
-456.39%-20.08M
-21.94%-54.98M
99.26%-150K
-100.49%-23.15M
-155.53%-28.07M
End cash Position
-22.07%213.4M
-20.79%232.79M
-20.79%232.79M
-19.32%237.25M
-20.13%253.35M
-20.69%273.83M
-15.76%293.91M
-15.76%293.91M
-20.32%294.06M
-16.65%317.21M
Free cash flow
44.89%-19.44M
-23.36%-74.5M
-5,582.75%-16.14M
27.31%-17.33M
81.11%-5.76M
-508.50%-35.28M
-187.60%-60.4M
81.12%-284K
28.58%-23.84M
-160.39%-30.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 44.67%-19.44M-24.31%-74.27M-5,613.73%-16.23M27.83%-17.15M80.91%-5.76M-532.32%-35.14M-230.11%-59.75M54.85%-284K26.67%-23.76M-159.33%-30.14M
Net income from continuing operations -91.56%-26.96M18.73%-65.78M3.09%-29.08M-94.81%-13.45M46.68%-9.18M47.51%-14.08M-172.30%-80.94M-156.30%-30.01M57.45%-6.9M67.24%-17.22M
Operating gains losses -257.14%-33K-18.90%382K136.63%63K-15.84%170K-67.01%128K-60.38%21K101.39%471K---172K388.57%202K--388K
Depreciation and amortization -17.85%658K-14.64%3.03M-16.73%682K-16.34%763K-14.30%779K-11.39%801K19.85%3.54M0.49%819K10.28%912K23.34%909K
Change In working capital 109.01%2.57M-88.38%-39.2M-83.11%3.39M62.27%-10.37M84.43%-3.68M-379.45%-28.55M-381.93%-20.81M1,287.50%20.09M-4.80%-27.47M-125.09%-23.65M
-Change in receivables 139.83%4.22M-105.66%-1.59M-90.90%2.39M251.34%9.25M-188.56%-2.63M-311.66%-10.6M195.87%28.09M326.01%26.23M82.74%-6.11M-96.69%2.97M
-Change in prepaid assets -32.75%809K303.75%5M159.75%916K93.29%-57K230.23%2.94M-44.97%1.2M-310.82%-2.46M-351.72%-1.53M79.55%-850K-1,485.89%-2.26M
-Change in payables and accrued expense 85.15%-1.38M-332.24%-18.22M-14.09%3.11M-48.82%-10.46M-131.94%-1.61M-249.23%-9.26M377.67%7.85M136.62%3.62M-257.98%-7.03M149.71%5.05M
-Change in other current assets -29.63%658K-18.98%3.7M-6.82%861K2.14%955K7.39%945K-48.71%935K12.78%4.56M-10.64%924K-8.24%935K-12.35%880K
-Change in other current liabilities -9.20%-1.1M-15.61%-4.21M-9.30%-1.08M-9.31%-1.07M-53.20%-1.05M-2.02%-1.01M15.41%-3.65M10.98%-989K10.61%-977K36.06%-688K
-Change in other working capital 93.52%-636K56.76%-23.87M65.67%-2.8M33.10%-8.99M92.34%-2.27M-144.57%-9.82M-243.00%-55.21M-275.55%-8.16M-249.39%-13.43M-302.41%-29.61M
Cash from discontinued investing activities
Operating cash flow 44.67%-19.44M-24.31%-74.27M-5,613.73%-16.23M27.83%-17.15M80.91%-5.76M-532.32%-35.14M-230.11%-59.75M54.85%-284K26.67%-23.76M-159.33%-30.14M
Investing cash flow
Cash flow from continuing investing activities 124.82%34K64.51%-230K88K-126.25%-181K042.92%-137K77.66%-648K091.85%-80K7.34%-328K
Net PPE purchase and sale 124.82%34K64.51%-230K--88K-126.25%-181K--042.92%-137K77.66%-648K--091.85%-80K7.34%-328K
Cash from discontinued investing activities
Investing cash flow 124.82%34K64.51%-230K--88K-126.25%-181K--042.92%-137K77.66%-648K--091.85%-80K7.34%-328K
Financing cash flow
Cash flow from continuing financing activities -99.89%16K146.99%13.38M8,622.39%11.69M76.77%1.23M-712.82%-14.73M594.47%15.2M122.49%5.42M100.72%134K-96.83%693K2,456.38%2.4M
Net issuance payments of debt --0--0--0--0---15M--15M--0--0--0--0
Net common stock issuance ----1,699.56%12.27M--11.69M------------11.99%682K--0--------
Proceeds from stock option exercised by employees -91.79%16K-76.58%1.11M--05,718.18%640K-88.60%274K-91.09%195K77.51%4.74M-90.02%134K-99.11%11K2,456.38%2.4M
Cash from discontinued financing activities
Financing cash flow -99.89%16K146.99%13.38M8,622.39%11.69M76.77%1.23M-712.82%-14.73M594.47%15.2M122.49%5.42M100.72%134K-96.83%693K2,456.38%2.4M
Net cash flow
Beginning cash position -20.79%232.79M-15.76%293.91M-19.32%237.25M-20.13%253.35M-20.69%273.83M-15.76%293.91M-11.44%348.89M-20.32%294.06M-16.65%317.21M4.61%345.28M
Current changes in cash 3.43%-19.39M-11.17%-61.12M-2,867.33%-4.45M30.43%-16.11M27.03%-20.48M-456.39%-20.08M-21.94%-54.98M99.26%-150K-100.49%-23.15M-155.53%-28.07M
End cash Position -22.07%213.4M-20.79%232.79M-20.79%232.79M-19.32%237.25M-20.13%253.35M-20.69%273.83M-15.76%293.91M-15.76%293.91M-20.32%294.06M-16.65%317.21M
Free cash flow 44.89%-19.44M-23.36%-74.5M-5,582.75%-16.14M27.31%-17.33M81.11%-5.76M-508.50%-35.28M-187.60%-60.4M81.12%-284K28.58%-23.84M-160.39%-30.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More